Target Name: CYP51A1
NCBI ID: G1595
Review Report on CYP51A1 Target / Biomarker Content of Review Report on CYP51A1 Target / Biomarker
CYP51A1
Other Name(s): CYP51 | CYPL1 | CP51A_HUMAN | Lanosterol 14-alpha demethylase | Lanosterol 14alpha-demethylase (CYP51A1) | Cytochrome P450-14DM | Cytochrome P450 family 51 subfamily A member 1, transcript variant 1 | Cytochrome P450, 51 (lanosterol 14-alpha-demethylase) | P450-14DM | cytochrome P450-14DM | cytochrome P450 family 51 subfamily A member 1 | P450L1 | Lanosterol 14-alpha demethylase (isoform 1) | sterol 14-alpha demethylase | Cytochrome P450 51A1 | cytochrome P450LI | Sterol 14-alpha demethylase | CP51 | CYP51A1 variant 1 | CYPLI | Cytochrome P45014DM | cytochrome P45014DM | Lanosterol 14-alpha-demethylase | cytochrome P450 51A1 | cytochrome P450, family 51, subfamily A, polypeptide 1 | cytochrome P450, 51 (lanosterol 14-alpha-demethylase) | LDM | Cytochrome P450LI

CYP51A1: Key Regulator of Cellular Processes

CYP51A1, also known as CYP51, is a gene that encodes a protein known as CYP51A1. This protein is a key regulator of the synthesis of many different compounds, including drugs, toxins, and other substances that are produced by the body. It is found in most and tissues cells in the body and is responsible for catalyzing the metabolism of these substances.

One of the key functions of CYP51A1 is its role in drug metabolism. Many drugs are metabolized by CYP51A1, and the rate at which they are metabolized can have a significant impact on their effectiveness and safety. For example, the metabolite of the drug Atorvastatin, which is used to lower cholesterol levels, is metabolized by CYP51A1 and is inactivated as a result. Similarly, the metabolite of the drug warfarin, which is used to prevent blood clots, is also metabolized by CYP51A1 and is inactivated.

In addition to its role in drug metabolism, CYP51A1 is also involved in the metabolism of other substances that are not drugs. For example, it is involved in the metabolism of steroids, which are used to treat a variety of conditions, and in the of toxins, which are released by bacteria and other microorganisms.

CYP51A1 is also involved in the regulation of cellular processes. For example, it is involved in the synthesis of many important cell components, such as collagen, which is a protein that makes up the extracellular matrix of cells. regulation of cell signaling pathways, which are responsible for transmitting signals from cells to other cells and for controlling the behavior of cells.

CYP51A1 is a gene that plays a critical role in many different cellular processes in the body. It is involved in the regulation of drug metabolism, cellular signaling pathways, and the synthesis of important cell components. As a result, it is an attractive target for drug developers and researchers who are interested in understanding and manipulating the activity of this gene.

Protein Name: Cytochrome P450 Family 51 Subfamily A Member 1

Functions: Sterol 14alpha-demethylase that plays a critical role in the cholesterol biosynthesis pathway, being cholesterol the major sterol component in mammalian membranes as well as a precursor for bile acid and steroid hormone synthesis (PubMed:8619637, PubMed:9559662, PubMed:20149798). Cytochrome P450 monooxygenase that catalyzes the three-step oxidative removal of the 14alpha-methyl group (C-32) of sterols such as lanosterol (lanosta-8,24-dien-3beta-ol) and 24,25-dihydrolanosterol (DHL) in the form of formate, and converts the sterols to 4,4-dimethyl-5alpha-cholesta-8,14,24-trien-3beta-ol and 4,4-dimethyl-8,14-cholestadien-3beta-ol, respectively, which are intermediates of cholesterol biosynthesis (PubMed:8619637, PubMed:9559662, PubMed:20149798). Can also demethylate susbtrates not intrinsic to mammals, such as eburicol (24-methylene-24,25-dihydrolanosterol), but at a lower rate than DHL (PubMed:9559662)

The "CYP51A1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about CYP51A1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

CYP51A1-AS1 | CYP51A1P1 | CYP51A1P2 | CYP51A1P3 | CYP7A1 | CYP7B1 | CYP8B1 | CYREN | CYRIA | CYRIB | CYS1 | CYSLTR1 | CYSLTR2 | CYSRT1 | Cysteine Protease | CYSTM1 | CYTB | CYTH1 | CYTH2 | CYTH3 | CYTH4 | CYTIP | CYTL1 | Cytochrome b5 reductase | Cytochrome bc1 complex | Cytochrome c oxidase | Cytochrome P450 1A (CYP1A) | Cytochrome P450 26 | Cytochrome P450 3A (CYP3A) | Cytochrome P450 4A | Cytochrome P450 Enzymes | Cytohesin | Cytoplasmatic dynein | Cytoplasmic dynein complex | CYTOR | CYYR1 | CYYR1-AS1 | CZIB | D21S2088E | D2HGDH | DAAM1 | DAAM2 | DAAM2-AS1 | DAB1 | DAB1-AS1 | DAB2 | DAB2IP | DACH1 | DACH2 | DACT1 | DACT2 | DACT3 | DACT3-AS1 | DAD1 | DAG1 | DAGLA | DAGLB | DALRD3 | DANCR | DAND5 | DANT2 | DAO | DAOA | DAOA-AS1 | DAP | DAP3 | DAPK1 | DAPK1-IT1 | DAPK2 | DAPK3 | DAPL1 | DAPP1 | DARS1 | DARS1-AS1 | DARS2 | DAW1 | DAXX | DAZ1 | DAZ2 | DAZ3 | DAZ4 | DAZAP1 | DAZAP2 | DAZAP2P1 | DAZL | DBET | DBF4 | DBF4B | DBF4P1 | DBH | DBH-AS1 | DBI | DBIL5P | DBIL5P2 | DBIP2 | DBIRD complex | DBN1 | DBNDD1 | DBNDD2 | DBNL